FGR secures exclusive global graphene carbon paste production and sale rights
Highlights First Graphene enters exclusive agreement to develop, produce, market and sell graphene-based carbon paste products with Halocell Australia Carbon paste is a conductive coating used to improve performance across a range of flexible...
Prestige Biopharma and Biosidus Enter Exclusive License Agreement for Tuznue® Commercialization in Latin America
SINGAPORE, Nov. 26, 2025 /PRNewswire/ -- Prestige Biopharma, a biopharmaceutical company specializing in antibody therapeutics, today announced an exclusive license and supply agreement with Biosidus, a biotechnology company headquartered in Buenos...
ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics
Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology Pursues a "once-and-done" treatment paradigm for diseases with high unmet medical needs SEOUL, South Korea, Nov....
GenEditBio and ToolGen Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics
Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology Pursues a "once-and-done" treatment paradigm for diseases with high unmet medical needs SEOUL, South Korea and...
HitGen Receives New Funding to Discover Novel Therapeutics for Underserved Diseases
Company enters into new agreement with the Gates Foundation to identify novel drug leads targeting tuberculosis and malaria and new agents for non-hormonal contraception. CHENGDU, China, Nov. 20, 2025 /PRNewswire/ -- Shanghai Stock Exchange listed...
Shanton Pharma Completes EOP2 Meeting with US FDA for Refractory Gout Program
SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., Oct. 27, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech developing a novel treatment for...
UGREEN Makes Strategic Entry into US Market with NASync Products Set for Walmart
WILMINGTON, Del., Oct. 27, 2025 /PRNewswire/ -- UGREEN, a leading innovator in consumer electronics, is excited to announce that its NASync DXP2800 will arrive in 460 Walmart stores across the United States. UGREEN has always been committed to...
Gabriel India Limited signs joint venture with SK Enmove, part of the SK Group US $148 Billion- among South Korea's two largest conglomerates
The JV signals Gabriel India's evolution into a diversified auto systems and components major beyond only suspension and ride control Builds on recent expansions into sunroofs, fasteners, solar dampers as well as a strategic restructuring led by the...
China, Central Asia make continuous efforts to deepen agricultural cooperation
BEIJING, June 15, 2025 /PRNewswire/ -- A report from People's Daily: A Chinese wheat breeding expert from China's Northwest A&F University (left) shares wheat management techniques for the seedling stage with a local agricultural technician in...
Elpis Biopharmaceuticals and Singapore General Hospital Enter Research Collaboration Agreement to Develop Next Generation Allogeneic CAR Technologies
Agreement focuses on advancing armored and bi-specific CAR-γδTs for AML and multiple myeloma LEXINGTON, Mass. and SINGAPORE, June 4, 2025 /PRNewswire/ -- Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored...